InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Konstantinov Konstantin, Chief Technology Officer. Director active across 2 companies, notably Codiak BioSciences, Inc.. Cumulatively, 3 disclosures have been logged. The latest transaction was disclosed on 26 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations3 total
0534 shares0
Common Stock
SEC:0000899243-22-020283:0·
€19,6657,276 shares@ €2.7027100.0% of flow
Common Stock
SEC:0000899243-21-038063·
€19,6657,276 shares@ €2.702750.0% of flow
Common Stock
SEC:0000899243-21-038063:0·
3 of 3 declarations
About Konstantinov Konstantin
Konstantin Konstantinov is the Chief Technology Officer and Director at Codiak BioSciences, Inc. and REPLIGEN CORP. In this role, he is responsible for leading technological initiatives and innovation within these companies. With a strong background in the biopharmaceutical sector, he plays a key role in developing new technologies and products. His expertise is essential in ensuring that these companies remain at the forefront of innovation.
